Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
Riluzole treatment modulates KCC2 and EAAT-2 receptor expression and Ca2+ accumulation following ventral root avulsion injury.
What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo. Oncogene. 2018 08; 37(33):4546-4561.
View in:
PubMed
subject areas
Breast
Cell Line, Tumor
Drug Resistance, Neoplasm
Female
Humans
Hypoxia-Inducible Factor 1, alpha Subunit
Macrophage Migration-Inhibitory Factors
Reactive Oxygen Species
Signal Transduction
Triple Negative Breast Neoplasms
Tumor Microenvironment
Vascular Endothelial Growth Factor A
authors with profiles
Anjan K Pradhan